Title |
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
|
---|---|
Published in |
Scandinavian Journal of Urology, July 2009
|
DOI | 10.1080/00365590801943274 |
Pubmed ID | |
Authors |
Per Olov Hedlund, Jan-Erik Damber, Inger Hagerman, Svein Haukaas, Peter Henriksson, Peter Iversen, Robert Johansson, Peter Klarskov, Finn Lundbeck, Finn Rasmussen, Eberhard Varenhorst, Jouko Viitanen, The Spcg-5 Study Group, Per Olov Hedlund, Jan-Erik Damber, Inger Hagerman, Svein Haukaas, Peter Henriksson, Peter Iversen, Robert Johansson, Peter Klarskov, Finn Lundbeck, Finn Rasmussen, Eberhard Varenhorst, Jouko Viitanen, The Spcg-5 Study Group |
Abstract |
To compare parenteral estrogen therapy in the form of high-dose polyestradiol phosphate (PEP; Estradurin) with combined androgen deprivation (CAD) in the treatment of prostate cancer patients with skeletal metastases. The aim of the study was to compare anticancer efficacy and adverse events, especially cardiovascular events. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 2 | 3% |
United States | 1 | 2% |
Italy | 1 | 2% |
Unknown | 55 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 17% |
Student > Bachelor | 9 | 15% |
Student > Master | 8 | 14% |
Student > Postgraduate | 5 | 8% |
Researcher | 3 | 5% |
Other | 10 | 17% |
Unknown | 14 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 26 | 44% |
Nursing and Health Professions | 2 | 3% |
Computer Science | 2 | 3% |
Neuroscience | 2 | 3% |
Sports and Recreations | 2 | 3% |
Other | 9 | 15% |
Unknown | 16 | 27% |